Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-110810

Chief Financial Officer sold 6,457 shares at an average $7.46 ($48,184)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2024-09-27 Sale 10b5-1 −295 $7.51 $2,215 319,355 D
Catinazzo Thomas Chief Financial Officer 2024-09-27 Sale 10b5-1 −6,162 $7.46 $45,969 313,193 D
Open-market sales · 6,457 sh · avg $7.46 · $48,184
Loading xslF345X05/ownership.xml…